Skip to content
MedsAcross

Medicine

Entacapone 200 mg tablet

Entacapone · Oral
Available on requestPrescription onlyUS FDAGeneric name

Entacapone 200 mg tablet is a generic prescription medicine for oral use, made by 13 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…

Key facts

Active ingredient (INN)
Entacapone
Brand
Sold under the generic name
Strength
200 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 1000 tablets, 500 tablets and 15 more
Manufacturers
Alembic PharmaceuticalsIndiaAurobindo PharmaIndiaMacleods PharmaceuticalsIndiaAjanta PharmaIndiaSun Pharmaceutical IndustriesIndiaAmerican Health PackagingAphena Pharma Solutions - TennesseeAvPAKLannettMajor Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F) Manufactured for: Macleods Pharma USA, Inc.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N04BX02 Entacapone
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 April 2013
Identifiers
RxCUI 317094DailyMed set ID 56327e32-3b06-4144-91a0-bb1908842e33, 3d4ec829-7835-4d59-bc5b-6ce38811fba7, d9cc1327-5474-4136-970a-ec40c41975b2 +11NDC 33342-260, 60687-188, 65862-654 +11Application ANDA207210, ANDA203437, ANDA212601 +3

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet, film coated in 1 bottle46708-478-31Alembic PharmaceuticalsIndia6 January 2022
1000 tablet, film coated in 1 bottle46708-478-91Alembic PharmaceuticalsIndia6 January 2022
100 tablet, film coated in 1 bottle62332-478-31Alembic PharmaceuticalsIndia6 January 2022
1000 tablet, film coated in 1 bottle62332-478-91Alembic PharmaceuticalsIndia6 January 2022
100 tablet in 1 bottle27241-049-10Ajanta PharmaIndia31 August 2017
100 tablet, film coated in 1 bottle65862-654-01Aurobindo PharmaIndia19 June 2015
1000 tablet, film coated in 1 bottle65862-654-99Aurobindo PharmaIndia19 June 2015
100 tablet in 1 bottle33342-260-11Macleods PharmaceuticalsIndia6 June 2017
500 tablet in 1 bottle33342-260-15Macleods PharmaceuticalsIndia6 June 2017
100 tablet, film coated in 1 bottle47335-007-88Sun Pharmaceutical IndustriesIndia1 April 2013
100 tablet, film coated in 1 bottle, plastic0527-1830-37Lannett20 December 2018
100 tablet, film coated in 1 bottle, plastic64980-722-01Rising Pharma Holdings23 April 2026
100 tablet, film coated in 1 bottle0781-5578-01Sandoz4 June 2014
30 blister pack in 1 box, unit-dose / 1 tablet, film coated in 1 blister pack60687-188-21American Health Packaging2 June 2016
3600 tablet, film coated in 1 bottle71610-247-83Aphena Pharma Solutions - Tennessee7 March 2019
50 blister pack in 1 box, unit-dose / 1 tablet, film coated in 1 blister pack50268-295-15AvPAK5 December 2016
30 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack0904-6822-07Major Pharmaceuticals2 May 2024
30 tablet in 1 blister pack0615-8298-39Vangard Labs1 July 2019

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 19 October 1999Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Clinical summary

Entacapone is a catechol-O-methyltransferase inhibitor indicated as an adjunct to levodopa and carbidopa to treat end-of-dose “wearing-off” in patients with Parkinson’s disease. It is available as tablets for oral use. MedsAcross supplies Entacapone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Entacapone

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Entacapone 200 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.